Literature DB >> 25640062

Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.

Seyed Ali Gaskari1, Hongqun Liu1, Charlotte D'Mello1, George Kunos2, Samuel S Lee3.   

Abstract

BACKGROUND & AIMS: Cirrhosis is associated with blunted cardiovascular response to stimuli such as hemorrhage, but the mechanism remains unclear. We aimed to clarify the role of endocannabinoids in blunted hemorrhage response in cirrhotic rats.
METHODS: Cirrhosis was induced by bile duct ligation (BDL). Hemodynamics were measured. Cannabinoid receptor-1 (CB1) antagonist, AM251, and macrophage inhibitor gadolinium chloride (GdCl3) were administered. Myocardial levels of anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) were measured and resident monocytes and macrophages quantified by immunohistochemistry. Isolated cardiomyocyte contractility was measured before and after incubation with monocytes from BDL and sham controls.
RESULTS: Hemorrhage significantly decreased arterial pressure and left ventricular dP/dT. After hemorrhage, these changes quickly reversed in controls, but were severely prolonged in BDL rats. Chronic AM251 treatment restored this impaired response. AEA and 2-AG levels were increased in BDL hearts and further increased after hemorrhage. Sham hearts showed virtually no monocytes or macrophages before or after hemorrhage, whereas BDL hearts had significantly more white blood cells which further increased after hemorrhage. GdCl3 treatment significantly reduced cardiac endocannabinoid levels both at baseline and after hemorrhage. This treatment also restored cardiovascular response to hemorrhage in BDL rats but did not affect sham controls. Monocytes isolated from BDL rats more potently inhibited cardiomyocyte contractility than sham control monocytes.
CONCLUSIONS: The cirrhotic heart showed increased monocyte recruitment and endocannabinoid levels. CB1 blockade or GdCl3 treatment restored blunted cardiovascular response to hemorrhage. Endocannabinoids released by monocytes blunt cardiac response to hemorrhage. Preventing monocyte recruitment or blocking endocannabinoid signaling may improve cardiovascular homeostasis in cirrhosis.
Copyright © 2015 European Association for the Study of the Liver. All rights reserved.

Entities:  

Keywords:  AM251; CB-1; Cardiomyopathy; Cirrhosis; Endocannabinoids; Hemorrhage; Macrophages; Monocytes

Mesh:

Substances:

Year:  2015        PMID: 25640062      PMCID: PMC5045259          DOI: 10.1016/j.jhep.2015.01.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  42 in total

Review 1.  Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy?

Authors:  Samuel S Lee
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

Review 2.  The endocannabinoid system: a general view and latest additions.

Authors:  Luciano De Petrocellis; Maria Grazia Cascio; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

Review 3.  Portal hypertension and its complications.

Authors:  Arun J Sanyal; Jaime Bosch; Andres Blei; Vincente Arroyo
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 4.  Portal hypertension: from pathophysiology to clinical practice.

Authors:  Wim Laleman; Lien Landeghem; Alexander Wilmer; Johan Fevery; Frederik Nevens
Journal:  Liver Int       Date:  2005-12       Impact factor: 5.828

5.  Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy.

Authors:  Z Ma; Y Zhang; P M Huet; S S Lee
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

6.  Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats.

Authors:  Y Li; H Liu; S A Gaskari; D-M McCafferty; S S Lee
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

7.  Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.

Authors:  K Varga; J A Wagner; D T Bridgen; G Kunos
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

8.  Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor.

Authors:  Jie Liu; Sándor Batkai; Pál Pacher; Judith Harvey-White; Jens A Wagner; Benjamin F Cravatt; Bin Gao; George Kunos
Journal:  J Biol Chem       Date:  2003-08-29       Impact factor: 5.157

9.  Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.

Authors:  Luis M Ruilope; Jean-Pierre Després; André Scheen; Xavier Pi-Sunyer; Guiseppe Mancia; Alberto Zanchetti; Luc Van Gaal
Journal:  J Hypertens       Date:  2008-02       Impact factor: 4.844

10.  SHSST cyclodextrin complex prevents the fibrosis effect on CCl₄-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects.

Authors:  Cheng-Hsun Yang; Wei-Jen Ting; Cecilia Hsuan Day; Da-Tong Ju; Yu-Lan Yeh; Li-Chin Chung; Fu-Jenn Tsai; Chang-Hai Tsai; Yuhsin Tsai; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2014-05-08       Impact factor: 5.923

View more
  4 in total

Review 1.  Anandamide and its metabolites: what are their roles in the kidney?

Authors:  Joseph K Ritter; Guangbi Li; Min Xia; Krishna Boini
Journal:  Front Biosci (Schol Ed)       Date:  2016-06-01

Review 2.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

3.  Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy.

Authors:  Csaba Matyas; Katalin Erdelyi; Eszter Trojnar; Suxian Zhao; Zoltan V Varga; Janos Paloczi; Partha Mukhopadhyay; Balazs T Nemeth; György Haskó; Resat Cinar; Robim M Rodrigues; Yeni Ait Ahmed; Bin Gao; Pal Pacher
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.298

4.  Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats.

Authors:  Ki Tae Yoon; Hongqun Liu; Jing Zhang; Sojung Han; Samuel S Lee
Journal:  Clin Mol Hepatol       Date:  2022-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.